Pfizer Acquires Animal Health Products
EU - Pfizer Animal Health today announced that it has entered into an agreement to acquire multiple product franchises from Schering-Plough Corporation covering all major animal health species including cattle, swine, equine, and companion animal.
24 April 2008
1 minute read
Specifically, Pfizer Animal Health will acquire from Schering-Plough a number of animal health products for sale in the European Economic Area covering the following categories:
- Swine E. coli Vaccines
- Equine Influenza and Tetanus Vaccines
- Ruminant Neonatal and Clostridia Vaccines
- Rabies Vaccines
- Companion Animal Veterinary Specialty Products
- Parasiticides & Anti-inflammatories
The acquisition is subject to certain closing conditions, including antitrust approval. Terms of the agreement were not disclosed.
Pfizer Animal Health’s Europe President, Albert Bourla, said that the acquisition will enable Pfizer Animal Health Europe to build upon its comprehensive animal health solutions for veterinarians and their clients - farmers and pet owners - in Europe.
Bourla added, “We look forward to offering veterinarians additional preventative therapies and treatments along with our technical expertise and services to ensure that animals receive the best care possible.”
TheCattleSite News Desk
